AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells
AXL靶向治疗通过扩增TCF1+ CD8 T细胞恢复STK11/LKB1突变型非小细胞肺癌对PD-1阻断的敏感性
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2022.100554
Huiyu Li,Zhida Liu,Longchao Liu,Hongyi Zhang,Chuanhui Han,Luc Girard,Hyunsil Park,Anli Zhang,Chunbo Dong,Jianfeng Ye,Austin Rayford,Michael Peyton,Xiaoguang Li,Kimberley Avila,Xuezhi Cao,Shuiqing Hu,Md Maksudul Alam,Esra A Akbay,Luisa M Solis,Carmen Behrens,Sharia Hernandez-Ruiz,Wei Lu,Ignacio Wistuba,John V Heymach,Michael Chisamore,David Micklem,Hani Gabra,Gro Gausdal,James B Lorens,Bo Li,Yang-Xin Fu,John D Minna,Rolf A Brekken
肺癌
细胞生物学
肿瘤
T细胞
AXL
STK11
CD8
PD-1
T细胞